Certain chemical agents such as arsenic trioxide have been shown to be capable of restoring the conformation of multiple different p53 mutants into their original tumor suppressive function, indicating that mutant p53 proteins could be molecularly “differentiated” or “rescued” [42–45]. The gene discussed is TP53; the disease is neoplasm.